- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05840653
The Effect of Hope Placement Program on Dıagnosed Wıth MS
The Effect Of Posıtıve Psychotherapy-Based Hope Placement Program On The Level Of Determınatıon Of Hope And Lıve Goals In Indıvıduals Dıagnosed Wıth Multıple Sclerosıs
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Multiple Sclerosis (MS), causing damage to myelin sheath and axons; It is a chronic disease with diffuse demyelinating lesion of the Central Nervous System (CNS) that often affects young adults, progresses with attacks and remissions, and may bring about functional limitation, disability or decrease in quality of life (Ertekin et al., 2012; Kuşçu et al., 2012; Milanlıoğlu et al., 2014; Daniel et al., 2018). Although the exact etiology of Multiple Sclerosis is not known, it is thought that many genetic and environmental factors may be effective (Veauthier, 2015; Brownlee et al., 2016). Multiple Sclerosis is more common in women than in men (Mitchell et al., 2019). An average of 50 thousand individuals diagnosed with Multiple Sclerosis inTurkey, It is reported that there are more than 2.5 million worldwide (Evans et al., 2013; Kalıncık et al., 2013; Akdemir et al. 2017; Mitchell et al., 2019). According to the data of the Turkish Statistical Institute (TUIK, 2018), MS ranks sixth among the causes of death with 4.1%, and ranks first among the diseases that cause disability. As it can be understood from the high rates of disability and death, it is a disease that imposes great burdens on a person's life (Gümüş, 2018; Tuncay, 2018; Öz & Öz, 2019).
The chronic and irreversible nature of Multiple Sclerosis disease, the uncertainty and destructiveness of the disease process affect individuals physically over time, and can also cause many negative symptoms in terms of mental health. Studies have shown that MS disease; anxiety, depression, loss of life purpose, intense hopelessness and suicide (1-2-3-4).
Life purpose has been defined as struggling to achieve one's goals and creating meaning against existential neurosis. Goals reflect the meaning, goals, and life tasks that are central to the psychological well-being perspective. Kasser and Ryan (1996) defined Life Goals as long-term goals that an individual hopes to achieve. Emmons (1992) defined life goals as situations that individuals try to achieve through cognitive and behavioral strategies. If individuals have set goals for themselves in different branches, it can be said that individuals have clarified their life goals. Nair (2003) states that life goals are also affected by previous positive or negative experiences. Looking at the literature, it is seen that life goals are handled with different classifications. For example, Pesesschkian's (1996) classification of life goals can be cited in the context of positive psychotherapy. Pesesschkian states that people set life goals in the areas of body (via senses), achievement (through career-mind), relationship (through traditions) and spirituality (via intuition). According to Pesesschkian (1996), people benefit from the resolution of conflicts in life by trying to achieve the goals they set in these four areas. Having a life purpose increases the subjective well-being, life satisfaction and hope level of individuals 5).
According to the Turkish Language Association, hope, which is defined as "the feeling of trust arising from hope" and which indicates the feeling of having positive expectations for the future, positively affects mental health by giving people the feeling that they can cope with negative experiences that they may encounter in the future. Hopelessness, which is the opposite of hope, is a feeling that causes mental problems such as depression and suicide as well as negatively affecting the mental health of the individual and is a part of these clinical pictures. Despair was also approved as a nursing diagnosis by the North American Nursing Diagnostic Association in 1986. Hope, which is important for human life, is perceived as a healing factor that empowers people to cope with momentary difficulties and overcome grief, and paves the way for finding meaning in life.
Setting a life purpose has positive effects on hope. While a purposeful life increases the level of hope in people, it reduces hopelessness and causes the person to live a more meaningful life. The decrease or loss of hope and the purpose of life can cause significant problems for people. Negative symptoms such as depression, addiction or suicide may occur in people who have lost their life purpose and hope. In such cases, in addition to the biological treatment methods applied to the person, the application of psychosocial-based interventions allows the symptoms to be resolved more easily.
The fact that Multiple Sclerosis is a chronic, uncertain, and exacerbating disease causes a decrease in the level of determination of life purpose from time to time or permanently, and hopelessness in the person. Therefore, focusing on problems such as "hopelessness and decreased life purpose" in individuals diagnosed with MS, teaching how to recognize and cope with symptoms, Positive psychotherapy (PPT), one of the psychosocial-based intervention methods, is a therapy method with a humanistic approach, the theoretical foundations of which were established by Pesesschkian. There are three basic principles of therapy: hope, balance and consultation. It is believed that real and existing things are not just conflicts and illnesses, but that there are innate abilities in every human being that accompany these conflicts and symptoms. In Positive Psychotherapy, the symptoms and ailments in the person; It is positively reinterpreted, emphasizing real talents. Sharing the function of the existing symptom with the client increases the client's acceptance and hope for himself and his situation, which in turn activates the hope principle (6). Again, starting from the principle of hope, there is this positive starting point, the principle of hope, related to each individual and situation at the center of PPT. Being talent and capacity oriented activates hope in the client and forms the basis of the healing process (7). The two important concepts mentioned, "hopelessness and life goals are among the main concepts of PPT. Therefore, it is thought that PPT-based psychoeducation will have a positive effect on situations such as hopelessness and low life purpose level.
When the international and national literature is examined, it is seen that the studies on PPT are limited. In addition, it has been found that most of the studies are related to depression, substance use disorder or university students (8-9-10-11-12). Studies using positive psychotherapy in patients diagnosed with Multiple Sclerosis are quite limited (13). In this respect, the research provides an opportunity for an up-to-date approach to the psychosocial problems of MS patients, and provides originality and importance in terms of contributing especially to the field of nursing and not having encountered a similar research topic in the literature.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kübra GÜLIRMAK, MSc
- Phone Number: 095538501324
- Email: k_1058_g@hotmail.com
Study Contact Backup
- Name: Serap GÜLEÇ KESKİN, PhD
- Phone Number: 095536539101
- Email: dr.seraps@gmail.com
Study Locations
-
-
-
Samsun, Turkey, 55000
- SAMSUN
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Having been diagnosed with MS for at least 6 months,
- Not having a chronic disease diagnosis other than Multiple Sclerosis,
- Not having any diagnosed psychotic illness,
- Ability to read and write
- Being between the ages of 18-65,
- Not having a verbal or hearing disability that may affect communication,
- Owning a smart phone or computer,
- Ability to use the Internet, participate in online programs,
- Regular follow-up of psychoeducations,
- Participating in and completing all psychoeducational trainings,
- Filling the pretest and posttest questionnaires,
- Volunteering to participate in the study.
- Having an EDSS score of 6.5 and below. Exclusion Criteria
- Having a chronic disease other than Multiple Sclerosis,
- Not having any diagnosed psychotic illness,
- Having a verbal or hearing disability that may affect communication,
- Not having a smart phone or computer,
- Not having the ability to use the Internet or participate in online programs,
- Having an EDSS score of 6.5 and above.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental 1: Intervention group
Experiment 1 group will first be given a pre-test, then a 5-week hope placement program will be applied.
The final test will be administered after the program is completed.
|
The group that will receive 5-week positive psychotherapy-based hope placement psychoeducation
|
|
Experimental: experimental 2 group; Intervention group
A 5-week hope placement program will be applied to the experimental 2 group without the pre-test application.
After the program is completed, the final test will be administered.
|
The group that will receive 5-week positive psychotherapy-based hope placement psychoeducation
|
|
No Intervention: control 1 group; not Intervention group
only the pre-test will be applied, other than that, no intervention will be applied in the 5-week period.
Then the final test will be applied.
|
|
|
No Intervention: control 2 group; not Intervention group
No intervention will be applied during the pre-test application and the 5-week period.
then the final test will be administered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
experiment 1 and experiment 2 group level of determination of life purpose
Time Frame: 5 weeks
|
In the experimental 1 and 2 groups, it is expected that there will be a significant increase in the total score of the life goals determination scale compared to the first test.
|
5 weeks
|
|
experiment 1 and experiment 2 group hopelessness is to decrease.
Time Frame: 5 weeks
|
It is expected that there will be a significant decrease in the beck hopelessness scale total score in the experimental 1 and 2 groups compared to the first test.
|
5 weeks
|
|
control1 and control 2 group hopelessness is to decrease.
Time Frame: 5 weeks
|
No change in life purpose and hopelessness level in Experiment 2 and Experiment 2 groups
|
5 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: kübra gülırmak, MSc, Ondokuz Mayis University
- Principal Investigator: kübra gülırmak, msc, Ondokuz Mayıs University
Publications and helpful links
General Publications
- Cope, T. (2010). The inherently integrative approach of Positive psychotherapy. The Journal of Psychotherapy Integration 20(2), 203-250.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B.30.2.ODM.0.20.08/305
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on psychotherapeutic intervention
-
Tuğba AşkanCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteHospital Clinic of BarcelonaRecruitingSuicide, Attempted | Suicide PreventionSpain
-
Groupe Francais d'Epidemiologie PsychiatriqueUnknownPTSD Post Traumatic Syndrome DisorderFrance
-
Philipps University MarburgGerman Research FoundationRecruitingMajor Depressive Disorder (MDD)Germany
-
HaEmek Medical Center, IsraelUnknown
-
University of CoimbraFoundation for Science and Technology (FCT)CompletedDepressive Symptoms | Mild Cognitive Impairment | Anxiety StatePortugal
-
Fundacion para la Investigacion y Formacion en...Unknown
-
Government College University FaisalabadActive, not recruitingExperiences of Psychitherapeutic Outcomes in Women Victims of Domestic ViolencePakistan
-
Bispebjerg HospitalCompleted
-
Medical University of GrazUnknownAdherence Intervention Post TransplantationAustria